Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jhep.2020.06.015 | DOI Listing |
Publication Analysis
Top Keywords
reply "hcv
4
"hcv treatment
4
treatment cirrhotic
4
cirrhotic patients
4
patients a different
4
a different approach
4
approach patients
4
patients awaiting
4
awaiting liver
4
liver transplant"
4
Similar Publications
Editorial: PIVKA-II Facilitates Risk Stratification for HCC Following HCV Cure-Authors' Reply.
Aliment Pharmacol Ther
February 2025
Department of Medical Sciences, Liver Unit, University of Turin, Turin, Italy.
Reply to: "Unlocking hope: HCV re-treatment strategy for patients with active hepatocellular carcinoma".
JHEP Rep
December 2024
Department of Internal Medicine 1, University Hospital, Goethe University, Frankfurt, Germany.
Letter: Impact of HCV Eradication on Recurrence Pattern and Long-Term Outcomes in Patients With HCV-Related Hepatocellular Carcinoma Undergoing Radiofrequency Ablation. Authors' Reply.
Aliment Pharmacol Ther
January 2025
Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Reply to correspondence on "Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy".
Clin Mol Hepatol
October 2024
Division of Gastroenterology and Hepatology, Stanford University Medical School, Stanford, CA, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!